Biotrin International - Company Logo
 
 
  News
 
21st February 2008Epstein-Barr Virus – new Multi-test ELISA now available .....read more
 

Biotrin are pleased to announce the launch of a new multi-test ELISA kit for the detection of Epstein-Barr Virus (EBV).  This new product, manufactured by Vircell, includes reagents for the simultaneous detection of VCA IgG, EBNA IgG and VCA IgM antibodies.
The kit features a microtitre plate coated with specific purified antigens for each protein and has colour coded wells to allow e...  


 
30th January 2008Biotrin to distribute new POC product range in Ireland
 

Dublin, Ireland 29thJanuary 2008 – Biotrin are pleased to announce an exclusive new distribution agreement to market and sell the Medix Biochemica product range in Ireland.

Medix Biochemica, specialise in the manufacture of Point of Care tests for several medical conditions which can be used in both the clinical laboratory and doctor’s office setting.  T...  


 
17th January 2008Parvovirus B19 (Fifth disease) storyline to feature in next episode of ER
 

Parvovirus B19 (Fifth Disease) to feature in the next episode of ER click here to find out more

...  

 
18th December 2007Read our latest newsletter
 Bionews, the 4th edition of Biotrin International's Newsletter. Download now...  

 
13th December 2007Improvement to Biotrin HHV 6 IgG EIA product
 

As part of our continuous improvement service to our customers, we have made the following enhancements to the HHV 6 IgG Enzyme Immunoassay (EIA).

  • Inclusion of LSC – Lot Specific Constant. This number will be a batch specific number and it will be clearly stated inside the kit box lid. We have added an LSC to this product to minimise any lot to lot variation of resu...  

 
1st December 2007Christmas Greetings from Biotrin
 Biotrin wish all their customers a happy Christmas! Click Here...  

 
29th November 2007RVP IFA product update: AD14 detected
 A re emergence of Adenovirus serotype 14 (Ad14) was recently reported in the Morbidity and Mortality Weekly Report (MMWR) from the Centers for Disease Control and Prevention (CDC).

Ad14  was first described in the 1950’s and it is a rarely reported but recently emerging serotype of adenovirus that can cause severe and sometimes fatal respiratory illness in patients of all ag...  

 
29th November 2007 Biotrin launches new molecular controls
 

Biotrin has just added several new products to its range of Molecular controls which  it launched earlier this year.  The controls, manufactured by Vircell and distributed by Biotrin, are marketed and sold to all laboratories in Ireland who are currently testing samples by molecular techniques, such as PCR.   

The four new products added to t...  


 
14th September 2007Launch of Biotrin RSV Solo
 

Biotrin are pleased to announce the launch of Biotrin RSV Solo, a rapid RSV antigen detection assay for the accurate detection of RSV antigens in respiratory  samples 

Product Codes: V10RSV ( 10 Device Pack)
    &nbs...  


 
13th September 2007Parvovirus B19 IgG EIA Notice
 

Changes have been made to the Instructions for use for the Parvovirus B19 IgG EIA kit. This only effects kit from lot 75KT020 onwards. These changes do not affect the assay procedure. Click here to download the changes

...  

 
13th September 2007Parvovirus B19 IgM EIA Notice
 

Changes have been made to the Instructions for use for the Parvovirus B19 IgG EIA kit. This only effects kit from lot 76KT014 onwards. These changes do not affect the assay procedure. Click here to download the changes


 
2nd August 2007Learn more now HHV-6
 

To learn more about our HHV products.

...  

 
13th April 2007Learn more now - human Metapneumovirus (hMPV) EIA
 

Download information on Biotrin's new Human Metapneumovirus (hMPV) EIA kit

...  

 
20th March 2007Biotrin Wins Best New Product At International Conference
 

Biotrin Biomarkers

March 16th 2007, Dublin, Ireland – Biotrin is delighted to announce that they have been awarded Best New Product, Preclinical Development, at the 14th International Molecu...  


 
14th March 2007Biotrin International annouce exclusive agreement with Vircell
 

26th February 2007

Biotrin International announced today an exclusive agreement with Vircell S.L. to distribute their complete product line in the Irish market.

Vircell S.L. based in Granada, Spain are a privately owned biotechnology company established in 1991 who specialise in providing a range of ready to...  


© 2005 Biotrin International
For further information on Fifth Disease click here
Website Design by Net Affinity

93 The Rise, Mount Merrion, Co. Dublin, Ireland.
Tel: +353 1 283 1166 | Fax: +353 1 283 1232 | Email: info@biotrin.ie
For technical support please email customercare@biotrin.ie
Company No. 422701